Page last updated: 2024-08-23

desogestrel and Activated Protein C Resistance

desogestrel has been researched along with Activated Protein C Resistance in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's8 (80.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al Dieri, R; Bloemen, S; Hemker, HC; Ten Cate, H; Ten Cate-Hoek, A1
Algra, A; Bouma, BN; Grobbee, DE; Kemmeren, JM; Meijers, JC2
Bouma, BN; Deguchi, H; Griffin, JH; Lee, YM; Middeldorp, S1
Bertina, RM; Dahm, AE; Helmerhorst, FM; Rosendaal, FR; Rosing, J; Sandset, PM; van Vliet, HA1
Bouma, BN; Büller, HR; Christella, M; Curvers, J; Meijers, JC; Middeldorp, S; Nicolaes, GA; Prins, MH; Rosing, J; Tans, G; Thomassen, LG1
Skegg, DC1
Kluft, C1
Bouma, BN; Büller, HR; Curvers, J; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; Thomassen, MC1
Curvers, J; Rosing, J; Tans, G1

Reviews

1 review(s) available for desogestrel and Activated Protein C Resistance

ArticleYear
Oral contraceptives, thrombosis and haemostasis.
    European journal of obstetrics, gynecology, and reproductive biology, 2001, Volume: 95, Issue:2

    Topics: Activated Protein C Resistance; Contraceptives, Oral; Desogestrel; Female; Hemostasis; Humans; Norpregnenes; Risk Factors; Venous Thrombosis

2001

Trials

5 trial(s) available for desogestrel and Activated Protein C Resistance

ArticleYear
Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2002, Volume: 13, Issue:5

    Topics: Activated Protein C Resistance; Adult; Carboxypeptidase B2; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Factor V; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Levonorgestrel; Thrombophilia

2002
Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide.
    Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:5

    Topics: Activated Protein C Resistance; Chromatography, High Pressure Liquid; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Glucosylceramides; Humans; Levonorgestrel; Pilot Projects; Protein C; Protein S; Prothrombin Time; Risk; Sensitivity and Specificity; Venous Thrombosis

2005
Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
    Lancet (London, England), 1999, Dec-11, Volume: 354, Issue:9195

    Topics: Activated Protein C Resistance; Adolescent; Adult; Contraceptives, Oral, Synthetic; Cross-Over Studies; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Protein C; Risk Factors; Thrombin; Thromboembolism

1999
A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Thrombosis and haemostasis, 2000, Volume: 84, Issue:1

    Topics: Activated Protein C Resistance; Adolescent; Adult; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombins; Biomarkers; Blood Coagulation; Blood Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Netherlands; Partial Thromboplastin Time; Protein C; Protein C Inhibitor; Protein S; Thrombin; Thrombophilia

2000
Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Thrombosis and haemostasis, 2002, Volume: 87, Issue:2

    Topics: Activated Protein C Resistance; Adult; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Factor IX; Factor V; Factor VII; Female; Humans; Levonorgestrel; Peptide Fragments; Prothrombin; Thrombophilia

2002

Other Studies

4 other study(ies) available for desogestrel and Activated Protein C Resistance

ArticleYear
Procoagulant effect of vitamin K antagonists?
    Journal of thrombosis and haemostasis : JTH, 2011, Volume: 9, Issue:12

    Topics: Activated Protein C Resistance; Androstenes; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Female; Humans; Lipoproteins; Protein S; Thrombophilia

2011
Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor.
    Journal of thrombosis and haemostasis : JTH, 2008, Volume: 6, Issue:2

    Topics: Activated Protein C Resistance; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipoproteins; Middle Aged; Protein S; Thrombophilia

2008
Third generation oral contraceptives.
    BMJ (Clinical research ed.), 2000, Jul-22, Volume: 321, Issue:7255

    Topics: Activated Protein C Resistance; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Norpregnenes; Progesterone Congeners; Randomized Controlled Trials as Topic; Risk Factors; Thromboembolism

2000
Renewed interest in haemostasis changes induced by oral contraceptives (OCs)
    Thrombosis and haemostasis, 2000, Volume: 84, Issue:1

    Topics: Activated Protein C Resistance; Adult; Biomarkers; Blood Coagulation Factors; Blood Proteins; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Genetic Predisposition to Disease; Hemostasis; Humans; Levonorgestrel; Partial Thromboplastin Time; Randomized Controlled Trials as Topic; Thrombophilia; Venous Thrombosis

2000